Search results for " release"

showing 10 items of 535 documents

Hunting for the high-affinity state of G-protein-coupled receptors with agonist tracers: Theoretical and practical considerations for positron emissi…

2019

Abstract The concept of the high‐affinity state postulates that a certain subset of G‐protein‐coupled receptors is primarily responsible for receptor signaling in the living brain. Assessing the abundance of this subset is thus potentially highly relevant for studies concerning the responses of neurotransmission to pharmacological or physiological stimuli and the dysregulation of neurotransmission in neurological or psychiatric disorders. The high‐affinity state is preferentially recognized by agonists in vitro. For this reason, agonist tracers have been developed as tools for the noninvasive imaging of the high‐affinity state with positron emission tomography (PET). This review provides an…

Central Nervous SystemBETA-ADRENERGIC-RECEPTORpositron emission tomographyagonist high-affinity stateD-2/3 AGONISTG-protein-coupled receptorsReview ArticleReceptors G-Protein-Coupledchemistry.chemical_compound0302 clinical medicineDrug DiscoveryReceptorNeurotransmitterReview Articles0303 health sciencesmedicine.diagnostic_testNONHUMAN PRIMATE BRAINEndocytosisTEST-RETEST REPRODUCIBILITYPositron emission tomographyG‐protein‐coupled receptors030220 oncology & carcinogenesisENDOGENOUS OPIOID RELEASEMolecular MedicineIN-VIVO BINDINGSignal TransductionAgonistNoninvasive imagingexperimental designmedicine.drug_classNeurotransmissionRAT-BRAINneurotransmittersagonist high‐affinity state03 medical and health sciencesIn vivomedicineAnimalsHumanshuman brain030304 developmental biologyG protein-coupled receptorPharmacologyDOPAMINE D2(HIGH) RECEPTORS5-HT1A RECEPTORSchemistryPositron-Emission TomographyPET RADIOLIGANDRadiopharmaceuticalsNeuroscienceMedicinal research reviews
researchProduct

Understanding retention and metabolization of aroma compounds using an in vitro model of oral mucosa.

2020

International audience; The mechanism leading to aroma persistence during eating is not fully described. This study aims at better understanding the role of the oral mucosa in this phenomenon. Release of 14 volatile compounds from different chemical classes was studied after exposure to in vitro models of oral mucosa, at equilibrium by Gas-Chromatography-Flame Ionization Detection (GC-FID) and in dynamic conditions by Proton Transfer Reaction- Mass Spectrometry (PTR-MS). Measurements at equilibrium showed that mucosal hydration reduced the release of only two compounds, pentan-2-one and linalool (p < 0.05), and suggested that cells could metabolize aroma compounds from different chemical fa…

Chemical structureTR146/MUC1 cellsAcyclic MonoterpenesKinetics01 natural sciencesGas Chromatography-Mass SpectrometryAnalytical Chemistrychemistry.chemical_compoundEating0404 agricultural biotechnologyLinaloolPentanonesmedicineMoleculeHumans[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringOral mucosaaroma persistenceSalivaAromaaroma metabolismVolatile Organic Compoundsbiologyoral mucosaChemistry010401 analytical chemistryaroma retentionMouth MucosaEthyl hexanoatefood and beverages04 agricultural and veterinary sciencesGeneral Medicinebiology.organism_classification040401 food scienceIn vitro0104 chemical sciencesmedicine.anatomical_structureBiochemistrymucosal pelliclearoma releasein vitro modelOdorants[SDV.AEN]Life Sciences [q-bio]/Food and NutritionFood ScienceFood chemistry
researchProduct

Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.

2017

Food induced viscosity can delay disintegration and subsequent release of API from solid dosage form which may lead to severe reduction in the bioavailability of BCS type III compounds. Formulations of such tablets need to be optimized in view of this postprandial viscosity factor. In this study, three super disintegrants, croscarmellose sodium (CCS), cross-linked polyvinylpolypyrrolidone (CPD), and sodium starch glycolate (SSG) were assessed for their efficiency under simulated fed state. Tablets containing these disintegrants were compressed at 10 and 30 KN, while taking lactose as a soluble filler. In addition to other compendial tests, disintegration force of these formulations was meas…

Chemistry PharmaceuticalPharmaceutical ScienceLactose02 engineering and technology030226 pharmacology & pharmacyDosage formExcipients03 medical and health sciencesViscosity0302 clinical medicineDrug DiscoverySodium Starch GlycolateImmediate releaseDissolutionPharmacologyFOOD EFFECTChemistryViscosityOrganic Chemistryfood and beveragesPovidoneStarch021001 nanoscience & nanotechnologyBioavailabilityChemical engineeringSolubilityFoodCarboxymethylcellulose Sodium0210 nano-technologyFederal stateTabletsDrug development and industrial pharmacy
researchProduct

Porous materials as delivery and protective agents for Vitamin A

2016

The suitability of porous materials to immobilize and release under control bioactive molecules prompted us to design and study delivery systems of Vitamin A (VitA). This molecule, relevant in several physiological functions, is easily oxidized. Commercial VitA was immobilized in two different clays, montmorillonite K-10 (MMT) and sepiolite (SEP), and in MCM-41, by impregnation. Characterization of the resulting hybrid materials by XRD, FTIR and 13C and 29Si (MAS) NMR spectroscopies revealed its presence. The photo-stability tests showed decreased degradation of VitA in the clays, compared to MCM-41 and the pure VitA, while thermostability is observed until ∼100 °C. The kinetics of the rele…

ChemistryGeneral Chemical EngineeringSepioliteKinetics020101 civil engineering02 engineering and technologyGeneral Chemistry021001 nanoscience & nanotechnologyControlled release0201 civil engineeringchemistry.chemical_compoundMontmorilloniteOrganic chemistryDegradation (geology)Fourier transform infrared spectroscopy0210 nano-technologyHybrid materialNuclear chemistryThermostabilityRSC Advances
researchProduct

Temperature and polymer crosslinking degree influence on drug transfer from alpha,beta-polyasparthydrazide hydrogel to model membranes. A calorimetri…

1998

Abstract A non-steroidal anti-inflammatory drug, diflunisal, has been chosen as drug model to be incorporated in α , β -polyasparthydrazide (PAHy) matrices to study the effect of polymer crosslinking degrees on the release processes from hydrogel ( X =0.4 and X =0.8) to a model membrane represented by unilamellar vesicles of dipalmitoylphosphatidylcholine. The technique employed to monitor these processes was differential scanning calorimetry that appears to be particularly suitable to follow the transfer kinetics of a drug from a controlled release system to void biomembrane model. The drug release from the two PAHy hydrogels differently crosslinked by glutaraldehyde to the lipidic model w…

ChemistryVesicleBilayertechnology industry and agriculturePharmaceutical ScienceBiological membraneControlled releasechemistry.chemical_compoundDifferential scanning calorimetryMembraneDipalmitoylphosphatidylcholinePolymer chemistrySelf-healing hydrogelsBiophysics
researchProduct

Tick saliva increases production of three chemokines including monocyte chemoattractant protein-1, a histamine-releasing cytokine

2014

Summary The effect of Ixodes ricinus tick saliva on the production of various cytokines and chemokines by mouse splenocytes was tested by a cytokine array. We demonstrated a strong upregulation of three chemokines, monocyte chemoattractant protein-1 (MCP-1), thymus-derived chemotactic agent 3 (TCA-3) and macrophage inflammatory protein 2 (MIP-2). MCP-1 could be induced by tick saliva itself. While TCA-3 and MIP-2 are engaged in Th2 polarization of the host immune response associated with tick feeding, MCP-1 may act as a histamine release factor, increasing blood flow into the feeding lesion thus facilitating tick engorgement in the late, rapid feeding phase.

ChemokineSalivaIxodes ricinusmedicine.medical_treatmentChemokine CXCL2ImmunologyBiologyHistamine ReleaseChemokine CCL1Micechemistry.chemical_compoundTh2 CellsImmune systemparasitic diseasesmedicineAnimalsSalivaChemokine CCL2IxodesMonocyteChemotaxisbiology.organism_classificationSpecific Pathogen-Free OrganismsMice Inbred C57BLCytokinemedicine.anatomical_structurechemistryImmunologybiology.proteinFemaleParasitologyHistamineParasite Immunology
researchProduct

Layered composite based on halloysite and natural polymers: a carrier for the pH controlled release of drugs

2019

We have prepared new biohybrid materials based on halloysite nanotubes and natural polymers (alginate and chitosan) for the controlled and sustained release of bioactive species. A functional nanoarchitecture has been designed allowing us to generate a layered tablet with a chitosan/halloysite nanocomposite film sandwiched between two alginate layers. The assembly of the raw components and the final structure of the hybrid tablet have been highlighted by the morphological and wettability properties of the prepared materials. Since the biohybrid has been designed as a smart carrier, halloysite nanotubes have been first loaded with a model drug (sodium diclofenac). The effect of the tablet th…

ChitosanNanocompositeComposite numberAlginateNatural polymersHalloysiteCompositeGeneral ChemistryDiclofenac Sodiumengineering.materialControlled releaseHalloysiteCatalysisChitosanchemistry.chemical_compoundchemistryChemical engineeringDrug deliveryMaterials ChemistryengineeringWetting
researchProduct

Core/Shell Gel Beads with Embedded Halloysite Nanotubes for Controlled Drug Release

2019

The use of nanocomposites based on biopolymers and nanoparticles for controlled drug release is an attractive notion. We used halloysite nanotubes that were promising candidates for the loading and release of active molecules due to their hollow cavity. Gel beads based on chitosan with uniformly dispersed halloysite nanotubes were obtained by a dropping method. Alginate was used to generate a coating layer over the hybrid gel beads. This proposed procedure succeeded in controlling the morphology at the mesoscale and it had a relevant effect on the release profile of the model drug from the nanotube cavity.

ChitosanNanotubeMaterials scienceNanocompositeAlginateNanoparticleHalloysiteDrug releaseSurfaces and Interfacesengineering.materialHalloysiteSurfaces Coatings and FilmsChitosangel beadschemistry.chemical_compoundChemical engineeringchemistryCoatinglcsh:TA1-2040Gel beadMaterials ChemistryengineeringMoleculelcsh:Engineering (General). Civil engineering (General)Layer (electronics)Coatings
researchProduct

2020

In this study, the potential for correlation between disintegration and dissolution performance of enteric-coated (EC) dosage forms was investigated. Different enteric hard shell capsule formulations containing caffeine as model drug were tested for disintegration (in a compendial disintegration tester) and for dissolution in both USP type I (basket) and type II (paddle) apparatuses using different media. Overall, good correlations were obtained. This was observed for both the basket and the paddle apparatus, indicating that the use of disintegration testing as a surrogate for dissolution testing (allowed by International Conference on Harmonization (ICH) for immediate release dosage forms …

ChromatographyChemistryPharmaceutical ScienceCapsule02 engineering and technology021001 nanoscience & nanotechnologyPositive correlation030226 pharmacology & pharmacySmall intestineDosage formIn vitro03 medical and health sciences0302 clinical medicinemedicine.anatomical_structuremedicineDissolution testingImmediate release0210 nano-technologyDissolutionPharmaceutics
researchProduct

Novel insights into excipient effects on the biopharmaceutics of APIs from different BCS classes: Lactose in solid oral dosage forms

2014

Excipients encompass a wide range of properties that are of importance for the resulting drug product. Regulatory guidelines on biowaivers for immediate release formulations require an in depth understanding of the biopharmaceutic effects of excipients in order to establish bioequivalence between two different products carrying the same API based on dissolution tests alone. This paper describes a new approach in evaluating biopharmaceutic excipient effects. Actually used quantities of a model excipient, lactose, formulated in combination with APIs from different BCS classes were evaluated. The results suggest that companies use different (relative) amounts depending on the characteristics o…

ChromatographyDrug CompoundingBiopharmaceuticsAdministration OralPharmaceutical ScienceExcipientLactoseBioequivalenceQuality by DesignDosage formBiopharmaceuticsExcipientschemistry.chemical_compoundchemistrymedicineHumansDrug productImmediate releaseLactosemedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct